Red Light Holland has announced that its U.S.-based research partner, Irvine Labs, has received a Controlled Substances Import Permit from the DEA, clearing the way for the importation of psilocybin truffles from the Netherlands to California.
The permit, granted after the DEA released its 2025 psilocybin quota in April, allows the companies to move forward with the shipment of 3 kilograms of raw psilocybin material from Red Light Holland’s facility in Horst. Irvine Labs, an FDA-compliant and DEA-registered operation, is licensed for prescription and over-the-counter drug manufacturing and is authorized to handle Schedule I substances including psilocybin, LSD, and DMT.
This milestone marks the latest step in a growing partnership focused on developing standardized microdosing capsules with extended shelf life. Using proprietary preservation techniques, the companies aim to refine dehydration and packaging processes that retain the integrity of natural psilocybin compounds. The ultimate goal is to produce a stable, scalable product that can be used in clinical trials and potential government-funded pilot programs in the United States.
“We are thrilled to announce this major milestone,” said Red Light Holland CEO Todd Shapiro. “This is a critical step in our mission to move from underground to mainstream, and we applaud the growing institutional support for psilocybin research.”
Irvine Labs President Shaun Land added, “Receiving the import permit clears the final regulatory hurdle for this stage of the project. We’re ready to begin work and apply our expertise in natural pharmaceuticals to support Red Light Holland’s microdosing initiative.”
The imported psilocybin will be used strictly for research and development. Both companies remain focused on ensuring full legal compliance as they work toward broader access and standardization of naturally derived psychedelic compounds.
